ArticleRadiology case reports2026
Endovascular treatment of superior petrosal sinus dural arteriovenous fistulas via combined transarterial and transvenous approach: Lessons from 2 cases.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Flow diverter for a dissecting aneurysm of the AICA serving as a feeding artery to a transverse-sigmoid sinus DAVF.Radiology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superior petrosal sinus (SPS) dural arteriovenous fistulas (DAVFs) often require endovascular treatment (EVT), with a combined transarterial/transvenous approach being a rare alternative. Case 1 involved a 61-year-old male with subarachnoid hemorrhage (SAH) diagnosed with a non-sinus-type SPS DAVF. The endovascular treatment utilized a combined transarterial/transvenous approach: A transvenous dual-lumen mini-balloon catheter was advanced into the SPS origin via the internal jugular vein (IJV) and sigmoid sinus (SS), while a transarterial balloon catheter was positioned in the external carotid artery (ECA). After temporary occlusion of the external carotid artery, transvenous Onyx injection failed to penetrate the fistula, the patient experienced a new postoperative subarachnoid hemorrhage, which resolved spontaneously, and follow-up angiography at 2 months confirmed complete DAVF obliteration. Case 2 involved a 63-year-old male diagnosed with a sinus-type SPS DAVF, where a combined transarterial/transvenous approach was employed: The carotid artery feeding arteries were embolized, the dilated SPS origin was catheterized via the internal jugular vein and sigmoid sinus, and the DAVF-feeding aneurysm on the basilar artery perforating artery was catheterized, followed by coiling of both the dilated SPS origin and the aneurysm, resulting in complete DAVF obliteration. Postoperatively, the patient reported facial numbness, which resolved after a 1-month course of mecobalamin tablet therapy. These cases demonstrate that for non-sinus-type SPS DAVF, occlusion of the SPS alone may carry a risk of hemorrhagic complications due to lack of fistula-site embolization. In contrast, for sinus-type SPS DAVF, embolizing the dilated SPS origin (as the fistula site) and the feeding artery may suffice for effective treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.